Log in
Mental and behavioural disorders

Body dysmorphic disorder

Body dysmorphic disorder is a psychiatric condition marked by persistent preoccupation with one or more perceived defects in physical appearance that are not observable or appear slight to others. It typically begins in adolescence and affects men and women roughly equally. The single most testable fact: patients perform repetitive behaviors (mirror checking, skin picking, excessive grooming) in response to appearance concerns, and insight is often poor or absent.

ICD-10F45.2
Typical patientAdolescent or young adult, perceived facial or skin flaw
Key findingRepetitive checking/camouflaging behaviors, poor insight
First-line treatmentSSRI plus cognitive behavioral therapy
5 min readFor medical studentsUpdated 2026-10-14

Definition and epidemiology

Body dysmorphic disorder (BDD) is classified in DSM-5 under obsessive-compulsive and related disorders, and in ICD-10 under F45.2 (hypochondriacal disorder), which groups dysmorphophobia with illness-preoccupation disorders. ICD-11 has since created a distinct body dysmorphic disorder category, but F45.2 remains the operative ICD-10 code tested in most exam contexts.

  • Lifetime prevalence is approximately 1.7-2.4% in the general population.
  • Onset is usually in early-to-mid adolescence (mean onset around 16-17 years), though diagnosis is often delayed by years due to shame and secrecy.
  • Roughly equal distribution between men and women, though the body areas of concern differ by sex (men more often focus on muscularity, build, and genitals; women more often on skin, hair, and weight).
  • Highly comorbid with major depressive disorder, social anxiety disorder, and obsessive-compulsive disorder (OCD).
  • A notable subset of patients seek and undergo cosmetic or dermatologic procedures, which rarely improve symptoms and may worsen distress.
High-yield for exams
  • BDD is classified under ICD-10 F45.2 and under OCD-related disorders in DSM-5.
  • Core features: preoccupation with a minimal/unobservable flaw plus repetitive checking/camouflaging behaviors.
  • Muscle dysmorphia specifier is seen predominantly in men and linked to anabolic steroid misuse.
  • Suicide risk in BDD is markedly higher than in the general population and must always be screened.
  • Cosmetic/surgical procedures do not reliably relieve BDD symptoms and should generally be avoided.
  • First-line treatment is an SSRI (often at higher doses, longer trial) combined with CBT including exposure and response prevention.
  • Insight varies widely, from good to delusional; absent-insight BDD can mimic delusional disorder, somatic type.
  • Must be distinguished from eating disorders, where preoccupation is limited to weight and shape.

Etiology and risk factors

The exact cause is unknown and is best understood as multifactorial, combining genetic vulnerability, neurobiological abnormalities, and environmental/sociocultural factors.

  • Genetic/family history: higher rates of BDD among first-degree relatives of OCD patients, suggesting shared heritability.
  • Neurobiological: abnormal visual processing favoring detail over holistic facial/body perception; serotonergic dysregulation (supported by SSRI responsiveness).
  • Temperamental: perfectionism, high aesthetic sensitivity, low self-esteem, childhood teasing or bullying about appearance.
  • Sociocultural: exposure to idealized body images (social media, fashion/beauty industry) is a contributing but not sufficient cause.
  • Childhood adversity: higher rates of childhood neglect or abuse reported in some cohorts.
  • Risk is increased in individuals with comorbid OCD, social anxiety disorder, or a history of major depression.

Pathophysiology

BDD is conceptualized as a disorder of both perception and cognition.

  • Visual processing abnormality: functional imaging studies show a bias toward detail-focused (local) visual processing rather than configural (whole-face/holistic) processing, particularly in the left hemisphere, when patients view their own face or body.
  • Cognitive distortions: selective attention to minor or imagined flaws, overvaluation of appearance as central to self-worth, and catastrophic interpretation of others' perceptions ('everyone notices my nose').
  • Fronto-striatal circuitry: overlap with OCD circuitry (orbitofrontal cortex, caudate) is proposed to underlie the compulsive, repetitive checking and grooming behaviors.
  • Reinforcement loop: compulsive behaviors (mirror checking, camouflaging, skin picking) provide brief anxiety relief but reinforce the preoccupation long-term, similar to the compulsion cycle in OCD.

Clinical features

Core features are preoccupation with a perceived appearance defect plus repetitive behaviors performed in response to that preoccupation.

  • Preoccupation: with one or more perceived flaws in appearance that are not observable or appear only slight to others (commonly skin, hair, nose, or overall body build/muscularity).
  • Repetitive behaviors/mental acts: mirror checking, excessive grooming, skin picking, comparing self to others, camouflaging (makeup, clothing, posture), seeking reassurance.
  • Insight: ranges from good to absent/delusional; many patients are convinced the flaw is real and obvious.
  • Muscle dysmorphia: a specifier, mostly in men, with preoccupation that one's body is too small or insufficiently muscular; associated with anabolic steroid misuse and compulsive exercise.
  • Functional impairment: social withdrawal, school/work avoidance, high rates of suicidal ideation and attempts.
  • Symptoms must cause clinically significant distress or impairment and not be better explained by an eating disorder (where concern is limited to body weight/shape).

Diagnosis

Diagnosis is clinical, based on history; there is no laboratory or imaging test.

DSM-5 criteria (summary)

  • Preoccupation with one or more perceived defects/flaws in physical appearance that are not observable or appear slight to others.
  • Repetitive behaviors (e.g., mirror checking, skin picking, excessive grooming) or mental acts (e.g., comparing self to others) in response to the appearance concerns.
  • Preoccupation causes clinically significant distress or impairment.
  • Not better explained by concerns with body fat/weight in an eating disorder.
  • Specify if muscle dysmorphia present; specify degree of insight (good/fair, poor, absent/delusional).

Screening and assessment tools

  • Body Dysmorphic Disorder Questionnaire (BDDQ) – validated self-report screening tool.
  • Yale-Brown Obsessive Compulsive Scale Modified for BDD (BDD-YBOCS) – severity assessment.
  • Clinicians should directly ask about appearance concerns, as patients rarely volunteer them due to shame; also screen for suicidality, which is markedly elevated.

Differential diagnosis

ConditionDistinguishing feature
Eating disorder (anorexia/bulimia)Preoccupation limited to body weight/shape/fat, not isolated features
Obsessive-compulsive disorderObsessions/compulsions not limited to appearance
Social anxiety disorderFear of negative evaluation in general, not driven by a specific perceived flaw
Illness anxiety disorder (hypochondriasis)Preoccupation with having a serious illness, not appearance
Normal appearance concernsLack significant distress/impairment or repetitive behaviors
Delusional disorder, somatic typeAppearance belief held with absolute certainty and no insight at all (overlaps with BDD 'absent insight' specifier)
Trichotillomania/excoriation disorderHair pulling or skin picking as the primary disorder, not secondary to appearance preoccupation

Management

Management combines pharmacotherapy and psychotherapy; evidence base largely mirrors OCD treatment given shared serotonergic involvement.

First-line

  • Selective serotonin reuptake inhibitors (SSRIs): considered first-line pharmacotherapy; often require higher doses and longer trials (12-16 weeks) than for depression before judging efficacy.
  • Cognitive behavioral therapy (CBT) adapted for BDD: includes cognitive restructuring, exposure and response prevention (reducing mirror checking/camouflaging), and perceptual retraining. CBT and SSRIs can be combined, especially in moderate-severe cases.

Additional considerations

  • Avoid cosmetic/dermatologic/surgical procedures: these do not reliably reduce BDD symptoms and may increase distress or legal/interpersonal conflict with providers; patients should be screened for BDD before elective cosmetic procedures.
  • Clomipramine (tricyclic with strong serotonergic activity) is an alternative if SSRIs fail.
  • Augmentation: antipsychotics (e.g., low-dose addition) may be considered as augmentation in treatment-resistant cases, though evidence is limited.
  • Treat comorbid depression and screen regularly for suicidal ideation, as suicide risk is substantially elevated compared with the general population.
  • Family psychoeducation is useful, particularly in adolescents.

Complications and prognosis

  • Suicidality: markedly elevated rates of suicidal ideation and attempts compared with the general population and even compared with many other psychiatric disorders; routine screening is essential.
  • Chronic course: without treatment, BDD tends to be chronic and unremitting; comorbidities (depression, OCD, social anxiety, substance use) are common.
  • Functional impairment: social isolation, unemployment, academic dropout.
  • Procedure-seeking: repeated, often unsatisfying cosmetic/surgical procedures; occasional conflict or litigation against providers.
  • Prognosis: improves substantially with adequate trials of SSRIs and CBT; early recognition and treatment improve long-term outcomes.
Mnemonic

BDD = "MIRROR": Mirror checking, Insight varies, Repetitive behaviors, Resemblance concerns are minimal/unobservable to others, OCD-related and overlapping, Risk of suicide is high.

Practice questions

1. A 19-year-old man presents with a 3-year history of believing his jaw is 'too small and asymmetric,' though his jaw appears normal to the examiner. He checks mirrors over 20 times a day, has stopped attending classes, and recently researched jaw implant surgery. He denies depressed mood but reports significant distress. Which of the following is the most likely diagnosis?

Answer: B. The preoccupation with a specific, non-observable or minor perceived flaw (jaw asymmetry) combined with repetitive behaviors (mirror checking) and functional impairment is classic for body dysmorphic disorder. There is no mention of fixed, unshakeable certainty needed to call this a delusion, nor mood symptoms suggesting depression, making BDD the best answer over delusional disorder.

2. A 24-year-old woman with BDD related to perceived facial scarring has failed an adequate 12-week trial of fluoxetine at a maximally tolerated dose with no improvement. She has also completed 16 sessions of CBT with exposure and response prevention with only mild benefit. Which of the following is the most appropriate next step?

Answer: B. After failure of an adequate SSRI trial plus CBT, switching to clomipramine, a tricyclic with potent serotonergic activity, is an appropriate evidence-based next step in treatment-resistant BDD. Cosmetic procedures do not reliably improve BDD symptoms and are not recommended; antipsychotic monotherapy and inpatient admission are not indicated without evidence of psychosis or imminent danger.

3. A 17-year-old male bodybuilder is preoccupied with being 'too small' despite having well above-average muscle mass. He exercises compulsively for 4-5 hours daily, has stopped socializing to avoid missing workouts, and uses dietary supplements of unclear composition purchased online. Which specifier of body dysmorphic disorder best describes this presentation?

Answer: B. This presentation, preoccupation with insufficient muscularity or body build despite normal or above-average muscle mass, compulsive exercise, and often supplement or anabolic steroid use, is the muscle dysmorphia specifier of BDD, seen predominantly in young men. It is important to screen for anabolic steroid misuse in these patients given the described supplement use.

Frequently asked questions

What causes body dysmorphic disorder?

BDD arises from a combination of genetic vulnerability, abnormal visual processing that favors detail over holistic perception, serotonergic dysregulation, and environmental factors like childhood teasing or sociocultural pressure around appearance. No single cause has been identified. Family history of OCD and personal traits like perfectionism or low self-esteem increase risk. It is best understood as a biopsychosocial condition rather than a purely psychological or purely biological one.

What are the first symptoms of body dysmorphic disorder?

Early symptoms usually involve intrusive, distressing preoccupation with a specific body feature such as skin, hair, or nose, paired with behaviors like frequent mirror checking, camouflaging with makeup or clothing, or seeking reassurance about appearance. Onset is typically in early-to-mid adolescence. These behaviors escalate over time and begin to interfere with school, work, or social functioning, often prompting avoidance of social situations or photographs.

How is body dysmorphic disorder diagnosed?

Diagnosis is clinical and based on history, using DSM-5 criteria: preoccupation with a perceived appearance flaw that is not observable or appears slight to others, plus repetitive behaviors or mental acts in response, causing significant distress or impairment. There is no blood test or imaging study. Clinicians use screening tools like the BDD Questionnaire and must directly ask about appearance concerns, since patients rarely disclose them spontaneously.

Is body dysmorphic disorder curable?

BDD is not typically described as 'cured' but is highly treatable, with most patients achieving significant symptom reduction and improved functioning through SSRIs and cognitive behavioral therapy. Without treatment, the course tends to be chronic. With adequate, often prolonged treatment at higher SSRI doses combined with CBT including exposure and response prevention, long-term remission and good quality of life are achievable for most patients.

Body dysmorphic disorder vs eating disorder — what is the difference?

BDD involves preoccupation with a specific perceived flaw in appearance (such as skin, nose, or hair) that is not observable or appears minor to others, while eating disorders like anorexia nervosa involve preoccupation specifically with body weight, shape, or fatness. If appearance concerns are entirely limited to weight and shape, an eating disorder diagnosis takes precedence over BDD. The two can coexist but are diagnostically distinct.

Key drugs

Obsessive-compulsive disorderSocial anxiety disorderIllness anxiety disorder (hypochondriasis)Delusional disorder, somatic typeAnorexia nervosaExcoriation (skin-picking) disorderTrichotillomaniaMajor depressive disorder

Sources and further reading

StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: F45.2

Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.